Eli Lilly Sues Telehealth Companies Alleging Unlicensed Practice of Medicine Through Diagnosis and Prescription Services

Eli Lilly and Company has initiated legal action against multiple telehealth companies, alleging violations of corporate practice of medicine statutes. The lawsuits center on the pharmaceutical giant’s assertion that these firms are unlawfully practicing medicine through their telehealth services. Specifically, Lilly’s lawsuits claim these telehealth firms are engaging in activities that constitute the practice of medicine without proper licensing or oversight. These activities, according to the lawsuits, include diagnosing patients, prescribing medications, and managing treatment plans, all while allegedly circumventing regulations designed to ensure patient safety and quality of care. The core of Lilly’s argument rests on the legal principle that only licensed medical professionals can make medical decisions.

Newsflash | Powered by GeneOnline AI
Date: April 23, 2025

Related posts:

Tests on Sunglasses Show Deficiencies in Protection Against Ultraviolet Rays Revolutionary AI Tool Identifies Overlooked Brain Abnormalities in Epileptic Children Large-scale Study Pinpoints Key Interventions to Halt Hepatitis B Spread in Africa Breakthrough in Stroke Diagnosis: New AI Model Enhances Accuracy and Transparency

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後